Clinical efficacy and long-term immunogenicity of an early triple dose regimen of SARS-CoV-2 mRNA vaccination in cancer patients.

Annals of the Academy of Medicine, Singapore(2023)

Cited 2|Views37
No score
Abstract
This study demonstrates the benefit of early administration of the third dose among cancer patients.
More
Translated text
Key words
Cancer, oncology, SARS-CoV-2, third dose, vaccination
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined